EYET
Eyetech Pharmaceuticals, Inc.
Biopharmaceutical company developing and commercializing treatments for retinal diseases, including Macugen (pegaptanib sodium), a first-in-class anti-VEGF therapy for wet age-related macular degeneration.
CUSIP: 302297106HealthcareUS1 holder
Total Value
$830.0K
Total Shares
25.0K
Net Share Change
+25.0K
Activity
1 buying
Investor
Value
Shares
Weight
Change
